This article is more than 5 years old. Information may no longer be current.
Celiac disease prevalence expected to exceed 8 million cases by 2023
Click Here to Manage Email Alerts
A new market research report has estimated that the prevalence of celiac disease will increase to more than 8 million cases in the six major markets over the next 10 years, according to a press release.
The EpiCast report, based on a literature review and primary research results, was produced by epidemiologists and provides a 10-year age- and sex-stratified forecast for total and diagnosed prevalent cases of celiac disease in the six major geographical markets, which include the United States, France, Germany, Italy, Spain and the United Kingdom, the release said. By 2023, total prevalent cases of celiac disease are estimated to reach 8.08 million at a growth rate of 3.92% and diagnosed cases are expected to reach 1.11 million at a 4.61% growth rate throughout the six major markets.
“Current epidemiological studies estimate that celiac disease affects around 1% of the population in western countries, with a range of between 0.3-2.7%,” the release said.